Respiratory syncytial virus RSV Vaccines - Biotech, Pharma and Life Science Channel

05:35 EDT 17th September 2014 | BioPortfolio

Respiratory syncytial virus (RSV) infection, which manifests primarily as bronchiolitis and/or viral pneumonia, is the leading cause of lower respiratory tract infection in infants and young children. In the US, RSV LRT infection develops annually in 4-5 million children, and more than 125,000 children are admitted per year for RSV-related illness. RSV disease is the no.1 cause of hospitalization in babies under a year of age in the US. While a monoclonal antibody is commercially available to help prevent RSV disease in infants and children at high risk for severe lung disease from RSV, a RSV vaccine still is not on the market. A number of RSV vaccine candidates have entered clinical development and further are to follow. Also, next generation antibodies against RSV with improved features are in the development pipeline as well as new therapies based on silencing RSV RNA or inhibiting key targets of the virus.

News Articles [923 Associated News Articles listed on BioPortfolio]

NanoViricides Reports That Its CEO Dr. Seymour Will Be Interviewed about the Evolving Ebola Crisis on Fox Business News at 9PM EDT This Evening

NanoViricides, Inc. (NYSE MKT:NNVC) (the “Company”), a nanomedicine company developing anti-viral drugs, reported that its CEO, Eugene Seymour, MD, MPH will be a guest on “T...

Virology Publishes Genocea HSV-2 Antigen Discovery Paper

Genocea Biosciences, Inc. (NASDAQ: GNCA), a clinical-stage biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that the peer-reviewe...

Cats Lend a Helping Paw in Search for Anti-HIV Drugs

HAIFA, Israel and NEW YORK, Sept. 16, 2014 /PRNewswire-USNewswire/ -- If you're not making regular trips to the vet for your kitty these days, you may not know that cats can get AIDS too. The fel...

Trevena Granted Key U.S. Composition of Matter Patent for TRV130

Expansion of Intellectual Property Estate Strengthens Pain Program Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and develo...

13-Year-Old Boy with Failed Fontan Circulation Bridged to Transplant Using the SynCardia Total Artificial Heart, Published in Annals of Thoracic Surgery

TUCSON, Ariz., Sept. 16, 2014 /PRNewswire/ -- Surgeons at The Children's Hospital of Philadelphia describe in a case report the first successful use of a SynCardia temporary Total Artificial Heart (TA...

DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial

HOUSTON, Sept. 16, 2014 /PRNewswire/ -- DNAtrix, Inc., experts in oncolytic virus development, today announced that the first patient was treated with the company's lead product, DNX-2401, a repl...

NovaBiotics Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for Lynovex® for the Treatment of Cystic Fibrosis

Orphan drug designation coincides with dosing of first patients in PhIIa study Aberdeen, UK – 16 September 2014 – NovaBiotics Ltd, the Aberdeen-based clinical-stage biotechnology co...

Protein Sciences and Diamyd Medical Deepen Commitment to Develop New Treatment for Diabetes

MERIDEN, Conn. and STOCKHOLM, Sept. 16, 2014 /PRNewswire/ -- Protein Sciences Corporation and Diamyd Medical AB announced today that Protein Sciences has broadened its commitment to diabetes...

Linde Healthcare experts to present details on installation of medical oxygen storage and distribution systems at ASPE convention

MURRAY HILL, N.J. and NEW PROVIDENCE, N.J., Sept. 16, 2014 /PRNewswire/ -- Two Linde Healthcare experts will present a paper on the critical elements of installing and maintaining U.S.P. (Un...

Vaxxas Initiates Research Project on Advancing Next Generation Technology for Polio Vaccine Delivery

WHO to Provide Funding of Project, as Part of Its Efforts to Secure Lasting Polio-Free World Vaxxas, a biotechnology company commercializing a novel vaccine delivery pl...

Events [0 Results]

None

Companies [214 Associated Companies listed on BioPortfolio]

Ansun BioPharma

Ansun BioPharma is a clinical stage biopharmaceutical company focused on the development of unique host-directed anti-viral therapies for respiratory viruses. Ansun BioPharma has ...

Global Virus Network (GVN)

The Global Virus Network (GVN) is an independent, not for profit organization, comprised of leading medical virologists from Argentina, Australia, Belgium, Canada, China, France, ...

Teva Neuroscience Inc.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and...

Meridian Bioscience Inc.

Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and re...

ResMed

ResMed (NYSE: RMD and ASX: RMD.AX) is a leading developer, manufacturer and marketer of products for the screening, treatment and long-term management of sleep-disordered breathing (SDB) and other res...

Appian Medical

Appian Medical is leading the way in the innovation of mobile health technologies to solve the universal need for accessible, accurate and affordable consumer-directed diagnostics...

Redbiotec

Redbiotec is a privately held Swiss biopharmaceutical company founded in 2006 and based in Zurich-Schlieren. The company uses its proprietary rePAX® co-expression tec...

Carex Health Brands and Roscoe Medical

Roscoe Medical, headquartered in Strongsville, Ohio, is a major manufacturer and distributor of innovative healthcare products that promote independence and better living in the h...

Kala Pharmaceuticals Inc.

Kala Pharmaceuticals, Inc. is advancing innovative treatments for ocular diseases addressing significant needs in both front and back of the eye based on the company’s propri...

Agenus, Inc.

Agenus is an immuno-oncology company developing a portfolio of checkpoint modulators (CPMs), heat shock protein vaccines and adjuvants. Agenus’ checkpoint modulator programs ...

Clinical Trials [2346 Associated Clinical Trials listed on BioPortfolio]

An Open Label Pharmacokinetic, Safety And Efficacy Study Of Maraviroc In Combination With Background Therapy For The Treatment Of HIV-1 Infected, CCR5 -Tropic Children

The primary purpose of this study is to determine the pharmacokinetic properties (what the body does to maraviroc) and to determine a suitable dosing schedule of maraviroc in HIV-1 infecte...

Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart

Dengue viruses can cause dengue fever and other more severe forms of disease. This study will evaluate the safety and immune response to two doses of a dengue virus vaccine given 12 months...

Safety, Pharmacokinetics, and Pharmacodynamics of MK-8408 in Participants With Hepatitis C Infection (MK-8408-003)

This is a 3-part study of MK-8408 for participants with hepatitis C infection. Successive participants will be enrolled as dose levels are evaluated to find the maximum safe and well tole...

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders

This study will determine the HCV antiviral efficacy, safety, and tolerability of treatment with Ledipasvir/Sofosbuvir (LDV/SOF) fixed-dose combination (FDC) for participants with genotype...

A Multiple Dose Study of MK-5172 in Hepatitis C-Infected Participants (MK-5172-010)

This study will compare hepatic pharmacokinetics (PK) derived from liver tissue to plasma PK after administration of MK-5172 to participants with chronic hepatitis C virus (HCV) infection....

Effect of Gastric Lavage in Preventing Feeding Problems in Babies Born With Meconium Stained Amniotic Fluid

The purpose of the study is to evaluate the role of gastric lavage in preventing feeding problems in babies born through meconium stained amniotic fluid. It is a routine practice in many h...

Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection

Aim of the study is to assess the efficacy and safety of 24 weeks of oral Sofosbuvir/Ledipasvir fixed-dose combination (FDC) in subjects with HCV genotype 1 infection and HIV co-infection,...

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

The purpose of this study is to evaluate the safety of and immune response to an experimental DNA HIV vaccine followed by boosting with an experimental modified vaccinia HIV vaccine (MVA) ...

Study of Respiratory Physiology During High Flow Nasal Cannula Treatment in Preterm Neonates.

The most commonly used noninvasive respiratory support in preterm babies is Continuous Positive Airway Pressure (CPAP), which provides extra breathing support to babies who are breathing b...

Mesenchymal Stem Cell in Patients With Acute Severe Respiratory Failure

Although the advent of advanced medical support for respiratory failure, the mortality rate of acute severe respiratory failure is still high and the life quality is frequently compromised...

PubMed Articles [7427 Associated PubMed Articles listed on BioPortfolio]

Cardiovascular disease associated with the human immunodeficiency virus: an update.

With the advent of increasingly available antiretroviral therapy (ART), the life expectancy of HIV-infected persons is increasing. As they age, HIV-infected persons have increased propensity to typica...

Synthesis and Antiretroviral Activity of Novel 4'-Fluoro-5'-Deoxyphosphonic Acid Carbocyclic Nucleoside Analogs.

Novel 5'-deoxycarbocyclic purine phosphonic acid analogs with the 4'-electropositive moiety, fluorine were designed, and synthesized from glyceraldehyde. The cyclopentenol intermediate, 9, was success...

Infectious Diseases and Tropical Disease Pathology: SY16-3 PYTHIOSIS: AN ENDEMIC FATAL INFECTIOUS DISEASE.

Pythiosis is a life threatening infectious disease of humans and animals living in tropical and subtropical areas of the world. The causative agent is the fungus-like microorganism Pythium insidiosum,...

Consensus statement on respiratory care in pediatric neuromuscular diseases: Executive summary.

Extramedullary relapse of acute linfoblastic leukemia: report of a case.

The superior vena cava syndrome (SVCS) is considered an emergency and requires immediate treatment; therefore, the etiologic diagnosis is essential before deciding on its implementation. The managemen...

Ventilator Use, Respiratory Problems, and Caregiver Well-Being in Korean Patients With Amyotrophic Lateral Sclerosis Receiving Home-Based Care.

Aim: The purpose of this study was to describe the status of ventilator use, respiratory problems, and caregiver well-being relating to patients with amyotrophic lateral sclerosis (ALS) using a home-b...

Renal Pathology: SC23-2 RENAL TRANSPLANT PATHOLOGY: REVIEW AND UPDATE.

Renal transplant pathology forms an integral part of medical kidney diseases requiring a biopsy for diagnosis, prognosis and/or appropriate therapy. Often, multiple transplant biopsies are performed t...

Pulmonary Pathology: LC22-1 RESPIRATORY BRONCHIOLITIS WITH FIBROSIS: A FORM OF SMOKING-RELATED DISEASE.

A new smoking-associated lesion has been described in the pathology literature over the last few years by various names including RBILD with fibrosis, smoking-related interstitial fibrosis, and airspa...

Pulmonary Pathology: LC22-1 PROPOSED NEW CLASSIFICATION OF IDIOPATHIC INTERSTITIAL PNEUMONIAS.

This presentation reviews the histopathology of the IIPs since the 2002 ATS/ERS classification of IIPs in the light of the 2013 update. The seven histological patterns proposed in 2002 remain, with ...

Pediatric and Perinatal Pathology: SY21-4 RECENT DEVELOPMENTS IN THE PATHOBIOLOGY OF PTLD.

Post transplant lymphoproliferative disease (PTLD) represents a spectrum of lymphoproliferative processes that may develop in the immunocompromised host following stem cell and solid organ transplanta...

Medical and Biotech [MESH] Definitions

Vaccines or candidate vaccines used to prevent infection with RESPIRATORY SYNCYTIAL VIRUSES.

Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.

A species of PNEUMOVIRUS causing an important respiratory infection in cattle. Symptoms include fever, conjunctivitis, and respiratory distress.

An acute inflammatory disease of the upper RESPIRATORY TRACT, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are PARAINFLUENZA VIRUS TYPE 3; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; and METAPNEUMOVIRUS.

The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Infectious-diseases
Latest News Clinical Trials Research Drugs Reports Corporate
Infectious diseases are caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi; the diseases can be spread, directly or indirectly, from one person to another. Zoonotic diseases are infectious diseases of animals that can caus...

Advertisement
review and buy Respiratory syncytial virus RSV Vaccines market research data and corporate reports here

Channels Quicklinks